AIDS 2014 Dinner Programs

About the Program:

• Program Overview
• Target Audience
• Educational Objectives
• Course Director and Faculty
• Program Dates and Locations
• Accreditation Statement
• Credit Designation
• Sunshine Act
• Disclosure of Conflicts of Interest

Program Overview:

While an increasing number of options exist for effectively treating patients with HIV infection, many clinicians find it challenging to keep abreast of important developments in HIV therapeutics. To address this problem, this CME dinner program series will use case studies to highlight and discuss the relative merits and clinical significance of new findings in HIV medicine presented at the 20th International AIDS Conference (AIDS 2014). Because the focus of the dinner programs will be on case studies, participants will need to be familiar with data from AIDS 2014 that may be applied and discussed. Therefore, prior to attending a dinner program, participants will view an Internet presentation that summarizes and discusses the key data presented at AIDS 2014. As a result of this blended learning approach, participants will not only gain an increased understanding of key data presented at AIDS 2014, they will also be prepared to use these data in the clinic to address HIV-positive patients' health needs and provide the optimal care available, which will help to improve virologic suppression and antiretroviral adherence, increase the delivery of individualized care, reduce resistance and treatment failure, and improve patient outcomes and quality of life.

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc.. It is not a session created by or presented at AIDS 2014 and it is not sanctioned by AIDS 2014.

Back to Top

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

After completing this activity, the participant should be better able to:

• Use in a clinical setting findings from key new studies on HIV/AIDS diagnosis, management and treatment presented at AIDS 2014

• Employ the current treatment paradigms for HIV/AIDS, including the studies and data presented at AIDS 2014 to improve patient care

• Discuss with patients and colleagues the studies and data on newer therapies for HIV/AIDS presented at AIDS 2014 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS

Back to Top

Program Dates and Locations:

Back to Top 

Course Director:

Back to Top  

Back to Top

Back to Top

Sunshine Act:

As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.

Back to Top

Disclosure of Conflicts of Interest:

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Back to Top

 Supported by an educational grant from Gilead Sciences Medical Affairs.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.